How Much Would It Take To Earn $100 A Month From Merck Stock

Merck & Co. MRK is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.

It will report its Q4 2024 earnings on Feb. 4, 2025. Wall Street analysts expect the company to post an EPS of $1.89, up from $0.03 in the year-ago period. According to data from Benzinga Pro, quarterly revenue is expected to be $15.65 billion, up from $14.63 billion in the year-ago period.

Don't Miss:

• This Jeff Bezos-backed startup will allow you to become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.
• Commercial real estate has historically outperformed the stock market, and this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!

The 52-week range of Merck’s stock price was $94.48 to $134.63.

Merck’s dividend yield is 3.14%. During the last 12 months, it paid $3.24 per share in dividends.

The Latest On Merck

On Oct. 31, the company announced its Q3 2024 earnings, posting sales of $16.66 billion, up 4% year-over-year and beating the consensus estimate of $16.47 billion, as reported by Benzinga.

Merck reported adjusted EPS of $1.57, down from $2.13 a year ago, beating the consensus of $1.51. The pharmaceutical unit booked $14.94 billion in revenue, up 5% year-over-year. The increase was driven by growth in oncology and cardiovascular, partially offset by declines in diabetes, vaccines and virology.

See Also: CEO of Integris gathered a team of senior investment managers who have $34.22 billion in combined owned and managed assets in the West Coast — here’s how to invest in their private credit fund that targets 12% annual interest rate.

Merck revised and narrowed its full-year 2024 forecasts. The company expects 2024 sales of $63.6 billion –$64.1 billion, compared to prior guidance of $63.4 billion –$64.4 billion and a consensus of $64.2 billion. The U.S. pharma giant expects 2024 adjusted EPS of $7.72 –$7.77, compared to prior guidance of $7.94 –$8.04 and consensus of $7.74. The outlook reflects a net negative impact of $0.24/share related to business development transactions with Curon Biopharmaceutical and Daiichi Sankyo.

How Can You Earn $100 Per Month As A Merck Investor?

If you want to make $100 per month – $1,200 annually – from Merck dividends, your investment value needs to be approximately $38,217, which is around 371 shares at $103.09 each. 

Understanding the dividend yield calculations: When estimating, you need two key variables – the desired annual income ($1,200) and the dividend yield (3.14% in this case). So, $1,200 / 0.0314 = $38,217 to generate an income of $100 per month.

You can calculate the dividend yield by dividing the annual dividend payments by the stock’s current price.

Trending: Arrived Home's Private Credit Fund’s has historically paid an annualized dividend yield of 8.1%*, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum. 

The dividend yield can change over time due to fluctuating stock prices and dividend payments on a rolling basis.

For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40).

In summary, income-focused investors may find Merck stock an attractive option for making a steady income of $100 per month by owning 371 shares of stock. There may be more upside as investors benefit from the company's consistent dividend hikes. Merck has raised its dividend consecutively for the last 14 years. 

Check out this article by Benzinga for 3 more stocks offering high dividend yields. 

Interest Rates Are Falling, But These Yields Aren't Going Anywhere

Lower interest rates mean some investments won't yield what they did in months past, but you don't have to lose those gains. Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities.

Arrived Home's Private Credit Fund’s has historically paid an annualized dividend yield of 8.1%*, which provides access to a pool of short-term loans backed by residential real estate. The best part? Unlike other private credit funds, this one has a minimum investment of only $100. 

Looking for fractional real estate investment opportunities? The Benzinga Real Estate Screener features the latest offerings.